AcelRx Pharmaceuticals In... (ACRX)
NASDAQ: ACRX
· Real-Time Price · USD
0.86
0.06 (7.50%)
At close: Jan 09, 2024, 10:00 PM
AcelRx Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | -343K | -343K | -370K | 281K | 398K | 651K | 651K | 622K | 1.01M | 1.33M | 1.77M | 1.52M | 2.88M | 2.75M | 2.82M | 3.55M | 3.06M | 5.54M |
Cost of Revenue | 2.6M | 2.6M | 2.6M | n/a | n/a | 1.55M | 2.6M | 2.96M | 3.53M | 2.85M | 2.59M | 3.46M | 3.33M | 3.5M | 3.75M | 3.82M | 5.23M | 5.56M |
Gross Profit | 2.23M | 2.23M | 2.23M | n/a | 117K | -1.18M | -2.23M | -2.34M | -2.52M | -1.52M | -820K | -1.94M | -457K | -748K | -935K | -265K | -2.17M | -20K |
Operating Income | -8.19M | -8.77M | -10.09M | -16.89M | -21.61M | -21.31M | -22.4M | -16.34M | -19.66M | -29.26M | -32.93M | -37.38M | -39.38M | -35.82M | -35.97M | -37.03M | -37.44M | -34.26M |
Interest Income | -8.25M | -8.25M | -8.25M | -227K | 1.67M | 2.51M | 8.02M | 8.38M | 6.63M | 6.3M | 1.5M | 2.09M | 2.75M | 3.03M | 3.18M | 3.53M | 3.67M | 3.14M |
Pretax Income | -5.95M | -6.29M | -7.65M | -10.29M | -13.71M | -14.3M | -10.29M | -13.26M | -18.59M | 56.51M | 47.77M | 47.34M | 45.7M | -34.81M | -35.09M | -36.09M | -36.65M | -33.41M |
Net Income | -11.3M | -11.64M | -13M | -15.65M | -13.65M | -14.2M | -4.91M | -7.88M | -13.27M | 61.77M | 47.76M | 47.32M | 45.7M | -34.82M | -35.1M | -36.1M | -36.66M | -33.41M |
Selling & General & Admin | 6.33M | 6.5M | 7.53M | 9.66M | 10.21M | 10.52M | 11.99M | 12.89M | 15.9M | 20.05M | 23.11M | 28.91M | 32.29M | 34.16M | 34.47M | 32.82M | 31.78M | 30.66M |
Research & Development | 7.66M | 8.07M | 8.34M | 7.16M | 6.29M | 5.93M | 5.55M | 4.8M | 4.93M | 4.92M | 5.19M | 4.84M | 4.95M | 4.13M | 3.78M | 3.94M | 3.48M | 3.57M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.95M | 4.95M | 4.95M | 4.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 13.99M | 14.57M | 15.86M | 16.82M | 16.5M | 16.45M | 17.54M | 20.25M | 23.4M | 27.54M | 30.86M | 32.99M | 36.47M | 37.52M | 37.48M | 36.77M | 35.27M | 34.24M |
Interest Expense | -969K | -1.18M | -1.36M | -394K | -394K | 275K | 575K | 764K | 1.01M | 882K | 1.15M | 1.43M | 1.72M | 2.02M | 2.31M | 2.59M | 2.88M | 2.29M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 16.59M | 17.17M | 18.46M | 16.82M | 16.5M | 16.45M | 17.54M | 20.61M | 24.33M | 29.35M | 33.46M | 37.84M | 41.19M | 42.41M | 42.63M | 40.59M | 40.5M | 39.8M |
Income Tax Expense | 5.27M | 5.27M | 5.27M | -5K | -3K | n/a | -5.27M | -5.27M | -5.26M | -5.26M | -308K | 160K | 149K | 151K | 472K | 5K | 5K | 4K |
Shares Outstanding (Basic) | 34.53M | 20.04M | 16.26M | 16.36M | 14.26M | 14.26M | 12.67M | 16.76M | 10.92M | 10.89M | 7.41M | 7.38M | 7.36M | 7.28M | 6.38M | 5.96M | 5.96M | 5.66M |
Shares Outstanding (Diluted) | 34.53M | 20.04M | 16.26M | 16.36M | 14.26M | 14.26M | 12.67M | 16.76M | 10.92M | 10.89M | 7.41M | 7.38M | 7.36M | 7.28M | 6.38M | 5.96M | 5.96M | 5.66M |
EPS (Basic) | -0.65 | -0.7 | -0.87 | -1.75 | -1.66 | -1.91 | -1.14 | -1 | -1.86 | 8.14 | 6.46 | 6.27 | 5.81 | -5.39 | -5.8 | -6.6 | -7.2 | -7.24 |
EPS (Diluted) | -0.65 | -0.7 | -0.87 | -1.75 | -1.66 | -1.91 | -1.14 | -0.99 | -1.85 | 8.15 | 6.47 | 6.27 | 5.81 | -5.39 | -5.8 | -6.6 | -7.2 | -7.24 |
EBITDA | -13.35M | -13.93M | -15.25M | -16.77M | -14.43M | -14.08M | -9.4M | -11.8M | -16.45M | 63.83M | 55.52M | 55.43M | 54.15M | -30.84M | -30.81M | -31.99M | -32.25M | -29.68M |
EBIT | -183K | -183K | -183K | n/a | -3.31M | -7.28M | -7.09M | -10.73M | -13.91M | 61.05M | 52.58M | 65.75M | 64.4M | -15.81M | -15.81M | -33.5M | -33.77M | -31.12M |
Depreciation & Amortization | -2.2M | -2.2M | -2.2M | -2.2M | -311K | -262K | n/a | 2.39M | 919K | 1.33M | 1.49M | 1.77M | 1.82M | 1.94M | 1.97M | 1.89M | 1.9M | 1.82M |